Peripheral neuropathy remains one of the most challenging conditions to address effectively, particularly in patients with diabetes.

While red and near-infrared light therapy has become an increasingly important tool for supporting circulation, cellular function, and nerve health, one factor may influence therapeutic response: nitric oxide availability at the tissue level.

Emerging research into the relationship between nitric oxide, vascular function, and photobiomodulation is opening new possibilities for more comprehensive approaches to neuropathy care.

Do you have patients who have been diagnosed with peripheral neuropathy? If so, it’s vital they understand the condition falls under the larger umbrella of chronic pain. There are many causes of neuropathic pain, and they include everything from progressive nerve disease to infection or injury. One of the most frustrating aspects of this condition is that the discomfort can flare up at any time, seemingly untriggered. 
There’s a reason for this. Neuropathic pain occurs when the body sends unwarranted (and generally untriggered) pain signals to the brain. And the condition will continue to progress if left unchecked. 

​Keep reading for a breakdown of chronic pain disorder and peripheral neuropathy so that you can empower your patients. 

When clinicians think about infrared light therapy, wavelength is often the first—and sometimes only—technical consideration. While wavelength is undeniably critical, emerging research shows that how light is delivered into tissue matters just as much as what wavelength is used.
This distinction is especially important in the care of patients with peripheral neuropathy and chronic wounds, where circulation impairment, tissue hypoxia, and nerve dysfunction converge to dramatically increase the risk of ulceration and amputation.
At NeuropaCalm, device design decisions—particularly wide-angle, 180° illumination—are rooted in this science.

Peripheral neuropathy, a condition characterized by damage to peripheral nerves, affects millions worldwide, leading to pain, numbness, tingling, and muscular weakness. Traditionally, treatment options focused primarily on pharmaceutical interventions, but there is a growing recognition of the importance of patient-centered care in managing this complex condition. 

Patient-centric modalities emphasize the individual experiences and preferences of patients, ultimately fostering better engagement and outcomes. Let’s explore various patient-focused approaches to managing peripheral neuropathy, highlighting their effectiveness and potential to enhance the quality of life of your patients.

Peripheral neuropathy isn’t just a nuisance. For millions of Americans—especially those living with diabetes—it’s a ticking time bomb. Tingling feet, burning sensations, and numbness may seem manageable at first. But for many, these early warning signs mark the beginning of a devastating path: ulcers, infections, and too often, amputation.

According to the National Institute of Diabetes and Digestive and Kidney Diseases, 60–70% of people with diabetes will develop some form of neuropathy during their lifetime. Even more alarming, 85% of lower-limb amputations are preceded by a diabetic foot ulcer.

These numbers aren’t just statistics. They represent real patients—our patients—who are losing independence, mobility, and quality of life.

The question is: what are we, as providers, doing to promote amputation prevention?